Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Thompson

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Cancer|January 15, 1995
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostateM Aihara, P T Scardino, L D Truong, et al.
Oncogene|August 5, 2000
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisT L Timme, A Goltsov, S Tahir, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancerJ A Eastham, L D Truong, E Rogers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progressionG Yang, A M Stapleton, T M Wheeler, et al.
Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.
Cancer Gene Therapy|July 14, 2007
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancerH Wang, G Yang, T L Timme, et al.
Journal of the National Cancer Institute|July 5, 2001
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox virusesT S Griffith, M Kawakita, J Tian, et al.
The Journal of Urology|May 23, 1998
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic studyO Z Hampel, M W Kattan, G Yang, et al.
Human Gene Therapy|March 1, 1996
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer modelsJ A Eastham, S H Chen, I Sehgal, et al.
Endocrinology|March 1, 1994
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesisT L Timme, L D Truong, V W Merz, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Cancer|January 15, 1995
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostateM Aihara, P T Scardino, L D Truong, et al.
Oncogene|August 5, 2000
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisT L Timme, A Goltsov, S Tahir, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancerJ A Eastham, L D Truong, E Rogers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progressionG Yang, A M Stapleton, T M Wheeler, et al.
Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.
Cancer Gene Therapy|July 14, 2007
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancerH Wang, G Yang, T L Timme, et al.
Journal of the National Cancer Institute|July 5, 2001
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox virusesT S Griffith, M Kawakita, J Tian, et al.
The Journal of Urology|May 23, 1998
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic studyO Z Hampel, M W Kattan, G Yang, et al.
Human Gene Therapy|March 1, 1996
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer modelsJ A Eastham, S H Chen, I Sehgal, et al.
Endocrinology|March 1, 1994
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesisT L Timme, L D Truong, V W Merz, et al.
Pageof 13